sec filing
NN
AMEX · NNVC
NanoViricides, Inc.
Healthcare · Biotechnology
$1.04
Down-$0.02 (-1.92%)
Updated Sep 10, 2026, 11:51 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 23.05M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.87 – $1.93
- Volume
- 419.05K
- Avg. volume
- 305.78K
Price performance
NNVC price history
1M range · 20 trading sessions · Daily adjusted prices
NNVC closed at $1.04 after 20 trading sessions, down 24.09% for the selected period.
- Last close
- $1.04
- Period change
- -24.09%
- Period low
- $1.04
- Period high
- $1.38
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $1.08 | $1.11 | $1.03 | $1.04 | 419.05K |
| Sep 8, 2026 | $1.11 | $1.13 | $1.08 | $1.08 | 265.05K |
| Sep 4, 2026 | $1.15 | $1.17 | $1.10 | $1.12 | 489.46K |
| Sep 3, 2026 | $1.15 | $1.1899 | $1.14 | $1.15 | 307.01K |
| Sep 2, 2026 | $1.24 | $1.28 | $1.16 | $1.17 | 502.95K |
| Sep 1, 2026 | $1.24 | $1.2506 | $1.21 | $1.21 | 204.02K |
| Aug 31, 2026 | $1.29 | $1.33 | $1.24 | $1.25 | 399.36K |
| Aug 28, 2026 | $1.26 | $1.2761 | $1.22 | $1.24 | 189.22K |
| Aug 27, 2026 | $1.27 | $1.29 | $1.26 | $1.28 | 239.49K |
| Aug 26, 2026 | $1.29 | $1.32 | $1.27 | $1.28 | 180.8K |
| Aug 25, 2026 | $1.28 | $1.33 | $1.28 | $1.29 | 237.78K |
| Aug 24, 2026 | $1.31 | $1.31 | $1.26 | $1.27 | 252.44K |
| Aug 21, 2026 | $1.33 | $1.39 | $1.31 | $1.33 | 250.26K |
| Aug 20, 2026 | $1.33 | $1.37 | $1.30 | $1.31 | 204.35K |
| Aug 19, 2026 | $1.35 | $1.39 | $1.34 | $1.34 | 332.7K |
| Aug 18, 2026 | $1.35 | $1.375 | $1.32 | $1.35 | 265.79K |
| Aug 17, 2026 | $1.35 | $1.41 | $1.35 | $1.36 | 335.25K |
| Aug 14, 2026 | $1.37 | $1.40 | $1.35 | $1.38 | 205.73K |
| Aug 13, 2026 | $1.38 | $1.3999 | $1.34 | $1.36 | 194.43K |
| Aug 12, 2026 | $1.41 | $1.43 | $1.345 | $1.37 | 241.74K |
Latest NNVC news
The latest Smart Investors Daily articles mentioning NNVC.
Stock researchResearch & News · SID Coverage
Loading stock research…

